tiprankstipranks
Nanobiotix (NBTX)
NASDAQ:NBTX
US Market
NBTX
Nanobiotix
RESEARCH TOOLSreports

Nanobiotix (NBTX) Stock News & Sentiment

100 Followers
Nanobiotix Updates Share Capital and Voting Rights as of March 31, 2026
Premium
Company Announcements
Nanobiotix Updates Share Capital and Voting Rights as of March 31, 2026
4d ago
6K
NBTX
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
Premium
Ratings
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
10d ago
NBTX
Nanobiotix Extends Cash Runway to 2028 as JNJ-1900 Oncology Program Advances and 2025 Results Filed
Premium
Company Announcements
Nanobiotix Extends Cash Runway to 2028 as JNJ-1900 Oncology Program Advances and 2025 Results Filed
11d ago
6K
NBTX
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
Premium
Ratings
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
12d ago
NBTX
Nanobiotix Reports First Positive Phase 2 Data for NBTXR3 in Inoperable Stage 3 Lung Cancer
Premium
Company Announcements
Nanobiotix Reports First Positive Phase 2 Data for NBTXR3 in Inoperable Stage 3 Lung Cancer
12d ago
6K
NBTX
Nanobiotix Sets March 31 Release for Fourth-Quarter and Full-Year 2025 Results
Premium
Company Announcements
Nanobiotix Sets March 31 Release for Fourth-Quarter and Full-Year 2025 Results
16d ago
6K
NBTX
Nanobiotix Denies Takeover Intentions Amid Media Speculation
Premium
Company Announcements
Nanobiotix Denies Takeover Intentions Amid Media Speculation
17d ago
6K
NBTX
More NBTX News >

NBTX News on the Web

Nanobiotix Updates Share Capital and Voting Rights as of March 31, 2026
TipRanks News
Neutral
Nanobiotix price target raised to $36 from $26 at Guggenheim
TipRanks News
Bullish
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
TipRanks News
Bullish
Nanobiotix price target raised to $37 from $26 at Leerink
TipRanks News
Neutral
Nanobiotix FY25 Net Loss Narrows; Expects Cash Runway Through Early 2028; Stock Down
rttnews
Bullish
Nanobiotix Extends Cash Runway to 2028 as JNJ-1900 Oncology Program Advances and 2025 Results Filed
TipRanks News
Neutral
Nanobiotix (NBTX) Receives a Buy from Guggenheim
TipRanks News
Bullish
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
NBTX
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.75 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is NBTX’s Media Buzz Sentiment?
1 articles about NBTX were published this week. In an average week, 3.75 articles are published.
    What is NBTX’s weekly average amount of articles?
    In an average week, 3.75 articles about NBTX are published.
      What is NBTX’s News Sentiment?
      50% of articles about NBTX were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week